DK0629400T3 - Idebenon-holdige præparater til behandling af Alzheimer's syge - Google Patents

Idebenon-holdige præparater til behandling af Alzheimer's syge

Info

Publication number
DK0629400T3
DK0629400T3 DK94303847T DK94303847T DK0629400T3 DK 0629400 T3 DK0629400 T3 DK 0629400T3 DK 94303847 T DK94303847 T DK 94303847T DK 94303847 T DK94303847 T DK 94303847T DK 0629400 T3 DK0629400 T3 DK 0629400T3
Authority
DK
Denmark
Prior art keywords
alzheimer
disease
treatment
idebenone
containing preparations
Prior art date
Application number
DK94303847T
Other languages
English (en)
Inventor
Akinobu Nagaoka
Giichi Goto
Masaomi Miyamoto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of DK0629400T3 publication Critical patent/DK0629400T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK94303847T 1993-06-18 1994-05-27 Idebenon-holdige præparater til behandling af Alzheimer's syge DK0629400T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14815493 1993-06-18

Publications (1)

Publication Number Publication Date
DK0629400T3 true DK0629400T3 (da) 2000-02-14

Family

ID=15446472

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94303847T DK0629400T3 (da) 1993-06-18 1994-05-27 Idebenon-holdige præparater til behandling af Alzheimer's syge

Country Status (8)

Country Link
EP (1) EP0629400B1 (da)
JP (1) JPH0761923A (da)
AT (1) ATE184788T1 (da)
CA (1) CA2125822A1 (da)
DE (1) DE69420776T2 (da)
DK (1) DK0629400T3 (da)
ES (1) ES2136167T3 (da)
GR (1) GR3032041T3 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19549262C2 (de) * 1995-02-08 1997-10-09 Martin Dr Kohlmeier Präparat zur Abschätzung des Entstehungsrisikos eines beschleunigten Verlustes kognitiver Fähigkeiten
EP0788793A1 (en) 1996-02-01 1997-08-13 Takeda Chemical Industries, Ltd. Idebenone for the treatment of dementia
DE69712888D1 (de) 1996-07-11 2002-07-04 Takeda Chemical Industries Ltd ZUSAMMENSTELLUNGEN DIE beta-AMYLOID PROTEIN BEDINGTE ZYTOTOXIZITÄT VERHINDERN
US5962535A (en) * 1997-01-17 1999-10-05 Takeda Chemical Industries, Ltd. Composition for alzheimer's disease
EP0952826B1 (en) * 1997-01-17 2001-11-14 Takeda Chemical Industries, Ltd. Idebenone containing combination agent for treating alzheimer's disease
AU8562998A (en) * 1997-08-12 1999-03-01 Takeda Chemical Industries Ltd. Idebenone-containing preparation for percutaneous administration
JP2003226639A (ja) * 2002-01-31 2003-08-12 Hisamitsu Pharmaceut Co Inc 神経成長因子活性増強剤としてのビタミンｋ類を含む医薬組成物およびその使用
AR055453A1 (es) * 2004-01-06 2007-08-22 Creactivar S A Uso de la idebenona en una composicion destinada a ser aplicada sobre la piel y composicion que la comprende
EP2471530B1 (en) 2005-06-01 2017-01-11 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
US9278085B2 (en) 2006-02-22 2016-03-08 Edison Pharmaceuticals, Inc. Side-chain variants of redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
EP2344142B1 (en) 2008-09-10 2024-06-26 PTC Therapeutics, Inc. Treatment of pervasive developmental disorders with redox-active therapeutics
WO2014035356A1 (en) * 2012-08-31 2014-03-06 Mahmut Bilgic Tablet formulations comprising a quinone derivative active agent
WO2017106803A1 (en) 2015-12-17 2017-06-22 Bioelectron Technology Corporation Flouroalkyl, flouroalkoxy, phenoxy, heteroaryloxy, alkoxy, and amine 1,4-benzoquinone derivatives for treatment of oxidative stress disorders
US12310967B2 (en) 2017-12-21 2025-05-27 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising motor neuron diseases
US12274703B2 (en) 2017-12-21 2025-04-15 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising a dementia
WO2020132378A2 (en) 2018-12-22 2020-06-25 Gliapharm Sa Compositions and methods of treatment for neurological disorders comprising depression
EP4351545A1 (en) 2021-06-07 2024-04-17 Katholieke Universiteit Leuven Idebenone in the treatment of drug resistant epilepsy

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08768B2 (ja) * 1989-08-24 1996-01-10 武田薬品工業株式会社 神経成長因子分泌誘導剤

Also Published As

Publication number Publication date
GR3032041T3 (en) 2000-03-31
EP0629400A1 (en) 1994-12-21
DE69420776D1 (de) 1999-10-28
ES2136167T3 (es) 1999-11-16
JPH0761923A (ja) 1995-03-07
DE69420776T2 (de) 2000-05-18
EP0629400B1 (en) 1999-09-22
CA2125822A1 (en) 1994-12-19
ATE184788T1 (de) 1999-10-15

Similar Documents

Publication Publication Date Title
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
DE69331409D1 (de) Oral 1alpha-hydroxyprevitamin d
DE69127470D1 (de) Verstärkung der unterdrückungsregulation von autoimmunkrankheiten durch orale oder enterale verabreichung von autoantigenen
ATE76747T1 (de) Levodopa-methyl-ester enthaltende pharmazeutische zusammensetzungen, ihre herstellung und therapeutische verwendungen.
DE69533492D1 (de) Orale Metoprolol-Dosisform des Typs "einmal täglich"
NO308194B1 (no) Anvendelse av benzotiofener i kombinasjon med bisfosfonater for fremstilling av et preparat for inhibering av bentap, samt et farmasøytisk preparat
IL86423A0 (en) Pharmaceutical compositions for the treatment of alzheimer's disease
DE69333387D1 (de) Pharmazeutische Zusammensetzungen enthaltend Norastemizol.
ATE38151T1 (de) Bestaendige 5-adenosyl-l-methionin-salze enthaltende, pharmazeutische zusammensetzungen fuer orale anwendung.
DK623984A (da) Farmaceutisk doseringsenhed
DK0642338T3 (da) Anvendelse af (E)-2-(p-fluorphenethyl)-3-fluorallylamin i behandlingen af Alzheimers sygdom
FI953725L (fi) Ornitiiniaminotransferaasi-inhibiittorien käyttö lääkeaineen valmistamiseksi Alzheimerin taudin hoitamiseksi
DE69131521D1 (de) Alpha-Ergocryptine enthaltende pharmazeutische Zusammensetzungen mit nervenschützender Wirkung
OA09766A (en) "Treatment of anxiety in benzodiazepine-withdrawn patients".
ES2101982T3 (es) Composicion conteniendo una alta dosis de vitamina a.
GEP20002141B (en) Use of 2-Phenyl-1, 2-Benzisoselenazol-3(2H)-One for Prevention and/or Treatment of Dementia, a Pharmaceutical Composition for Prevention and/or Treatment of the Alzheimer’s Disease